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ABSTRACT
There is an increase in the numbers of neural precursors in
the SVZ (subventricular zone) after moderate ischaemic
injuries, but the extent of stem cell expansion and the
resultant cell regeneration is modest. Therefore our studies
have focused on understanding the signals that regulate
these processes towards achieving a more robust amp-
lification of the stem/progenitor cell pool. The goal of the
present study was to evaluate the role of the EGFR [EGF
(epidermal growth factor) receptor] in the regenerative
response of the neonatal SVZ to hypoxic/ischaemic injury.
We show that injury recruits quiescent cells in the SVZ to
proliferate, that they divide more rapidly and that there is
increased EGFR expression on both putative stem cells and
progenitors. With the amplification of the precursors in the
SVZ after injury there is enhanced sensitivity to EGF, but
not to FGF (fibroblast growth factor)-2. EGF-dependent SVZ
precursor expansion, as measured using the neurosphere
assay, is lost when the EGFR is pharmacologically inhibited,
and forced expression of a constitutively active EGFR is
sufficient to recapitulate the exaggerated proliferation of
the neural stem/progenitors that is induced by hypoxic/
ischaemic brain injury. Cumulatively, our results reveal that
increased EGFR signalling precedes that increase in the
abundance of the putative neural stem cells and our
studies implicate the EGFR as a key regulator of the
expansion of SVZ precursors in response to brain injury.
Thus modulating EGFR signalling represents a potential
target for therapies to enhance brain repair from
endogenous neural precursors following hypoxic/ischaemic
and other brain injuries.
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INTRODUCTION
A number of studies have demonstrated that the brain
possesses a limited regenerative capacity following injury
(Magavi et al., 2000; Arvidsson et al., 2002; Parent et al.,
2002; Goings et al., 2004; Ohab et al., 2006). These
investigations have predominantly evaluated neuronal pro-
duction in the adult brain following injury (Jin et al., 2001;
Zhang et al., 2001; Plane et al., 2004). Although encouraging,
the extent of cell replacement is limited. However, by
understanding the adaptive mechanisms that occur in the
SVZ (subventricular zone) subsequent to injury, therapeutic
strategies can be designed to achieve a more significant level
of regeneration after CNS (central nervous system) injury.
Brain injury, as a consequence of cardio-respiratory
insufficiency, is the most common cause of morbidity in
premature and term infants. In the US alone, it has been
estimated that one in every eight babies is born premature,
and that over 80 000 infants per year are born very pre-term.
Up to 40% of the infants born pre-term and weighing less
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problems ranging from classic cerebral palsy to mild learning
deficits that may not appear until later in life (Volpe, 2001).
There is an even larger cohort of infants that acquire
developmental brain injuries as a consequence of insults such
as intrauterine infection or asphyxia at birth. Presently, there
are limited treatments available to prevent brain damage
from injuries sustained in the perinatal period and there are
no approved therapeutic regimens to stimulate CNS regen-
eration.
EGFRs [EGF (epidermal growth factor) receptors] are
expressed in the infant, juvenile, young adult and adult
human SVZs (Weickert et al., 2000), as well as on actively
dividing cells in the postnatal rodent SVZ (Seroogy et al.,
1995; Weickert and Blum, 1995). EGFR and its ligands
maintain embryonic and adult neural stem cells (Doetsch et
al., 1999; Junier, 2000; Yarden, 2001; Doetsch et al., 2002)
and promote the diversification of neural precursors during
embryonic cortical development (Burrows et al., 1997;
Kornblum et al., 1997; Burrows et al., 2000; Caric et al.,
2001). Postnatally, EGFR confers a motile phenotype to non-
migratory cortical neuronal progenitors (Aguirre et al., 2005).
Surprisingly, there are very few studies on the role of EGFR in
the regenerative responses of the neural stem/progenitor cells
following brain damage (Justicia and Planas, 1999; Teramoto
et al., 2003).
Using a rodent model of neonatal brain injury, in the
present study we demonstrate that there is a robust increase
in EGFR signalling in both neural stem cells and progenitors.
We also show that the regenerative response can be
recapitulated in vitro by transfecting NSPs (neural stem
progenitors) with a constitutively active EGFR, and that
pharmacologically inhibiting EGFR in vitro abrogates the
expansion of the NSPs observed subsequent to injury. The
results of the present study suggest that enhanced EGFR
expression is critical for NSP expansion.
MATERIALS AND METHODS
Neonatal H/I (hypoxia/ischaemia) model
All animal work was approved by the institutional animal care
and use committee guidelines of the New Jersey Medical
School. Timed pregnant Wistar rats (Charles River
Laboratories) were housed on a 12 h light/dark cycle at
25˚C with Purina rodent chow #5001. Following a normal
delivery, the litter size was culled to 12 pups per litter.
Neonatal H/I was induced on postnatal day 6 (P6) rat pups (P0
as day of birth) by a permanent right CCA (common carotid
artery) cauterization followed by systemic hypoxia. Briefly, P6
rat pups were anaesthetized with isofluorane (5% induction,
3% maintenance) following which a midline neck incision
was made. The right CCA was separated from the vagus nerve
and coagulated using a bipolar cauterizer (Malis bipolar
cauterize and bipolar cutter; Codman) at 10 V. The skin
incision was sutured using 4-0 silk and the pups were
returned to the dam for 2 h. For mouse neonatal H/I, the litter
size was culled to 12 pups per litter and permanent CCA
cauterization was performed on P10 pups as explained above
for rats. Prior to hypoxia, the pups were pre-warmed in jars
partially submerged in a 37˚C water bath for 20 min after
which rat pups were subjected to systemic hypoxia in jars at
8% O2/92% N2 for 75 min and mouse pups at 10% O2/92%
N2 for 65 min. Sham-operated control animals had their right
CCA separated from the vagus nerve, but it was not
coagulated. They were subjected to hypoxia. Following
hypoxia, the animals were left in the jars for 15 min at
normoxia, after which they were returned to their cages.
Primary neurosphere assay
After 3 days of recovery from H/I, P9 rat pups were
decapitated and their brains removed. Under aseptic condi-
tions, a cut was made 2 mm from the anterior pole of the
brain. A second cut was made approx. 3 mm posterior to the
first cut. The hippocampus, corpus callosum and the
meninges were removed under the microscope. Using forceps,
12 o’clock and 3 o’clock incisions were made and the region
enclosed between the cortex and the ventricle containing the
SVZ was removed and placed in fresh PGM [1 mM MgCl2 and
0.6% dextrose in PBS (pH 7.3)]. The tissue was mechanically
minced using forceps and then enzymatically dissociated
using 0.05% trypsin/EDTA at 37˚C for 7 min. The trypsin was
inactivated by the addition of an equal volume of newborn
calf serum and the tissue was resuspended in ProN media
[DMEM (Dulbecco’s modified Eagle’s medium)/F12 (1:1) media
containing 10 ng/ml D-biotin, 25 mg/ml insulin, 20 nM
progesterone, 20 mM Hepes, 100 mM putrescine, 5 ng/ml
selenium, 50 mg/ml apo-transferrin and 50 mg/ml gentamy-
cin] and triturated in ProN. The triturated suspension was
passed through a 40 mM Nitex screen and the cells were
collected by centrifugation at 200 g for 2 min and washed
with ProN. The cells were counted with 0.1% Trypan Blue dye
under a haemocytometer and plated at 5610
4 cells/ml in
ProN medium supplemented with 2 ng/ml EGF or 1 ng/ml FGF
(fibroblast growth factor)-2 or as stated. The cells were
cultured at 37˚Ci n5 %C O 2 incubators and fed every 2 days
by removing approx. half of the medium and replenishing
with fresh medium.
Neurosphere quantification
A neurosphere was defined as a free-floating cluster of at
least 25 mm diameter. Prior to counting the spheres, the
plates were shaken to ensure uniform distribution of the
spheres in the well. The number of neurospheres in five
random fields under 46magnification was determined for
each well. The total number of neurosphere-producing cells,
the neural stem/progenitor cells, in the population was
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the area of the field and the area of the well. For neurosphere
volumetric measurements, digital photographs were captured
from at least ten neurospheres from each condition (n56 SVZ
per condition) and volumes were calculated using IP Lab 3.6
software.
Immunofluorescence
Cryostat brain sections were collected from animals killed at
48 h of recovery. Sections were stained using a rabbit anti-
EGFR antibody (Santa Cruz Biotechnology, catalogue number
1005; used at a 1:100 dilution). Secondary antibodies were
LRSC (lissamine rhodamine sulfonyl chloride)-conjugated
goat anti-rabbit IgG (Jackson Immunoresearch). Sections
were thawed in ice-cold PBS and blocked with PGB super-
block (10% BSA and 10% normal goat serum in PBS) for 1 h
at room temperature (20˚C). The superblock was aspirated
and primary antibodies were applied in a 1:5 dilution of PGB
superblock and incubated overnight at 4˚C. The slides were
rinsed extensively with PBS and then incubated in secondary
antibodies for 1 h at 37˚C. The sections were washed,
counterstained with DAPI (49,6-diamidino-2-phenylindole),
and coverslipped with Gel Mount (Biomeda). To control for
non-specific staining, the primary antibody was replaced with
a 1:200 dilution of normal rabbit serum. Images were
obtained using a Zeiss LSM410 confocal laser-scanning
microscope using a 406 objective. The exposure time for
capturing the images was identical. Images were cropped and
assembled into a montage using Photoshop 9.0.
Flow cytometry
The SVZ was dissected out of 3 day H/I recovery and sham-
operated control P9 Wistar rat pups and dissociated as
described above. Approx. 2610
5 cells were used for each
analysis. The cells were incubated with a rabbit polyclonal
anti-EGFR antibody (Ab 15669, Abcam; used at a 1:50
dilution) together with either a mouse monoclonal anti-NG2
(neuro-glial protein 2; Millipore; used at a 1:100 dilution) or a
mouse monoclonal IgM anti-PSA-NCAM (poly-sialated neural
cell adhesion molecule; Millipore; used at a 1:500 dilution) for
1 h on ice. After several washes, the cells were incubated with
appropriate secondary antibodies conjugated with fluoro-
chromes for 1 h on ice protected from light. To analyse EGFR-
expressing cells in mice, subsequent to neonatal H/I, approx.
2610
5 cells were stained using a mouse IgM monoclonal
anti-SSEA-1 (stage-specific embryonic antigen-1)/LeX anti-
body (Zymed Laboratories). Following several washes, the cells
were incubated with biotin-conjugated anti-rabbit antibody
and then streptavidin-conjugated Alexa FluorH 488 for EGFR
detection, and RedX-conjugated anti-mouse IgM for LeX
detection for 1 h each on ice and protected from direct light.
The cells were analysed using a BD FACS Calibur
TM.A
population of unstained rat SVZ cells was used to calibrate
the BD FACS Calibur
TM machine prior to analysis. Negative
controls used included replacing the primary antibody with
normal rabbit serum (Jackson ImmunoResearch; used at a
1:3000 dilution) and normal mouse serum (Jackson
ImmunoResearch; used at a 1:3000 dilution) followed by
secondary and tertiary antibodies as described above. The
data were analysed using FlowJo version 4.4.4 software.
Western blot analysis
SVZ tissue dissected from H/I and sham-operated P9 rat pups
was homogenized with a tissue/lysis buffer ratio of 0.5 g of
tissue/2 ml of lysis buffer in a glass homogenizer (Kontes
glass homogenizer with Pestle ‘A’). The HES lysis buffer used
contained 10 mM Hepes, 1 mM EDTA and 250 mM sucrose
(pH 7.4) with 2 mM sodium orthovanadate and one tablet of
protease inhibitor (Complete Mini PI cocktail tablets; Roche
diagnostics) for 10 ml of buffer, added just prior to use. The
homogenate was spun at 1000 g for 10 min in a table top
Beckman centrifuge to pellet nuclei. The supernatant was
then spun at 150 000 g in a Beckman Ultracentrifuge with
the titanium SW55Ti swinging bucket rotor. This membrane-
enriched fraction was resuspended in HES buffer and the
protein concentration was estimated using the BCA (bicinch-
oninic acid) assay (Pierce Biotech). Total protein (30 mg) was
mixed with 46 NuPage LDS sample buffer and 106 NuPage
reducing agent and heated for 10 min at 90˚C and loaded on
to 4–12% NuPage Bis-Tris pre-cast gels (Invitrogen). Approx.
2 ml of MagicMark XP (Invitrogen) was loaded for standard
molecular mass markers. Following electrophoresis, the
proteins were transferred on to a nitrocellulose membrane
and stained with Ponceau S to evaluate equal protein loading
into the wells. The blots were blocked with 5% non-fat dried
skimmed milk/1% BSA in PBS-Tween followed by incubation
with primary antibody in 1% BSA in PBS-Tween overnight at
4˚C with gentle rocking. The primary antibodies used were
rabbit polyclonal anti-EGFR antibody (Ab 15669, Abcam; used
at a 1:250 dilution) or mouse monoclonal anti-phospho-
tyrosine-100 (Cell Signalling Technologies; used at a 1:2000
dilution). Following three rinses with PBS-Tween the
following day, the blots were incubated with the corres-
ponding secondary antibodies such as DAR-HRP (horseradish
peroxidase)-conjugated (Jackson Laboratories; used at a
1:10000 dilution) or DAM-HRP conjugated (Jackson laborat-
ories; used at a 1:5000 dilution) antibodies for 2 h at
room temperature. The blots were washed and the signal
developed with Western Lightning chemiluminescence
reagent (PerkinElmer) according to the manufacturer’s
protocol. The bands were visualized using UVP EpiChem
3
and processed with Labworks 4.0 digital quantification
software (UVP).
RNA isolation
SVZs were microdissected as outlined above and snap frozen
in 0.5 ml of TRIzolH (Invitrogen) per SVZ in a slush of dry ice/
ethanol and stored at 280˚C. Just prior to extraction, the
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97tissues were thawed and homogenized using a hand-held
tissue homogenizer. Chloroform (100 ml) was added per
sample and mixed to obtain a cloudy suspension that was
centrifuged at 800 g for 5 min, following which the aqueous
phase was transferred to a new tube. Approx. 250 ml of 70%
ethanol was added and the mixture was applied to an RNeasy
Mini-spin column (Qiagen) and the manufacturer’s protocol
was followed to remove contaminants. The purity and
amount of total RNA obtained was determined from the
absorbance values measured using a UV–visible spectropho-
tometer (Becton Dickinson). The total RNA concentration
was adjusted to 200 ng/ml and stored at 280˚C until further
use.
Real-time PCR
RNA from six SVZs was used per condition per group. Total
RNA (1 mg) was transcribed to cDNA using the Qiagen
Omniscript RT kit with random nanomers (Sigma–Aldrich) and
RNaseIN (Promega). Primer pairs for the gene of interest were
obtained from Taqman gene expression systems (Applied
Biosystems) and the 18S primers were obtained from Lux
primer design (Invitrogen, catalogue number 115HM-01). The
Platinum-UDP supermix kit (Invitrogen) was used for
reactions, which were carried out in 96-well plates and run
in an ABI Prism 7700 sequence detection system (Applied
Biosystems). Fold-changes in gene expression with reference
to the housekeeping gene 18S were analysed using the REST
(relative expression software tool) program (Pfaffl et al.,
2002)
Thymidine incorporation assay
At 72 h, post-H/I and sham-operated control rat pups were
decapitated and the SVZs dissected out as described above.
The SVZ cells were dissociated and cultures were set up at
3610
5 cells/ml in 20 ng/ml EGF in ProN overnight. The
following morning the cells were spiked with 8 mCi of
[
3H]thymidine. Starting every 4 h, the cells were collected on
Whatman 25 mm filters and washed once for 5 min in PBS,
followed by three washes for 10 min each with 5% TCA
(trichloroacetic acid). The filter papers were allowed to dry
and collected in scintillation vials and 5 ml of scintillation
fluid was added. The scintillation vials were measured in a
Beckman LS6500 Multipurpose Scintillation counter for the
amounts of [
3H]thymidine incorporated by analysing the
d.p.m. obtained. The data were normalized to a percentage of
the 4 h control value d.p.m. obtained. Three independent
experiments were performed and the graph was plotted as
the means¡S.E.M. of all three experiments.
Pharmacological EGFR inhibition assay
The SVZ was dissected out from rat pups 72 h post-H/I or
sham-operated control P9 rat pups as described above. The
cells were digested using trypsin and triturated to generate a
uniform cell suspension. Then, 5610
4 cells/ml were plated in
the following conditions in 6-well tissue culture plates: (i) 2
ng/ml EGF¡1 ng/ml FGF-2 in ProN; (ii) 2 ng/ml EGF¡1 ng/ml
FGF-2¡the pharmacological EGFR inhibitor PD153035
(Calbiochem) at 300 nM in ProN; and (iii) 2 ng/ml EGF¡1
ng/ml FGF-2¡PD153035 at 1 mM in ProN. The cells were
cultured 7 DIV (days in vitro) with media changes every 2
days. The number of neurospheres formed was quantified. To
ascertain that the decrease in neurospheres obtained upon
culturing SVZ cells with PD153035 was not due to cell death,
the cells cultured for 7 DIV in media containing the inhibitor
PD153035 were transferred to fresh medium containing 2 ng/
ml EGF¡1 ng/ml FGF-2 in ProN and cultured for an
additional 7 DIV. After 1 week, the number of neurospheres
obtained was quantified.
EGFR gain-of-function
Plasmid pEF2-Fl-Fc-cR1-IRES-EGFP [where IRES is internal
ribosome entry site and EGFP is enhanced GFP (green
fluorescent protein)] was digested with NheI and SpeI
followed by heat inactivation of the restriction enzymes.
The digested ends were dephosphorylated with shrimp
alkaline phosphatase to avoid vector re-ligation. Plasmid
pEf2-FLAF-EGFR was digested with NheI and XbaI to obtain
the EGFR fragment. This fragment was ligated to the vector
to obtain pEF2-fl-Fc-EGFR-IRES-EGFP. The resulting plasmid
was transfected into COS cells and the transfection resulted
in increased levels of phosphorylated EGFR as a proof of
concept (results not shown).
Primary neurospheres were generated from rat pup SVZs
and dissociated with accutase to yield single cells. Approx.
2610
6 cells/condition were used for pEGFR_IRES_EGFP and
pEGFP plasmid using the rat nucleofector kit (Lonza,
catalogue number VPG-1005). Mock transfection controls
had cells that were pulsed using the Amaxa system, but with
no added DNA. Fluorescence in the transfected cells was
readily evident by 24 h. At this time, experiments were
performed to assess cell division. Cells were diluted to 5610
4
cells/well in neurosphere growth medium, cultured in a six-
well tissue culture dish and allowed to form neurospheres
that were quantified at 3 days and 7 days post-transfection.
Other cells were incubated with 10 mM BrdU (bromodeoxy-
uridine) and samples were collected 6 and 12 h post-BrdU
addition and processed for BrdU incorporation analysis using
the BD Pharmingen BrdU Flow Kit.
Statistical analysis
Data were analysed using one-way ANOVA followed by
Tukey’s post-hoc test or Student’s t test to detect significant
differences between the means with P,0.05. Analyses were
performed using SAS (Cary). For real-time PCR data, the REST
program was used to detect significant differences between
the means of treatment groups and untreated controls based
on P values of 0.05.
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Neurosphere number and size increase following
H/I in the presence of EGF, but not FGF-2
The neurosphere has remained a standard assay for measuring
numbers of neural stem cells in the SVZ, therefore we isolated
SVZ cells to determine whether there was an increase in the
number of sphere-forming cells after neonatal H/I.
Neurosphere cultures of rat SVZs were established from
ipsilateral, contralateral and sham-operated control animals
72 h post-H/I. Spheres were propagated in a chemically
defined serum-free medium (ProN) supplemented with either
EGF (2 ng/ml) or FGF-2 (1 ng/ml). After 7 DIV, the number of
neurospheres obtained from the ipsilateral SVZ following
injury was 5-fold higher in medium supplemented with EGF
as compared with FGF-2 [1381.7¡105.2 compared with
261.5¡32.4 (means¡S.E.M.), n56 brains] (Figure 1B). There
was a significant difference in the number of neurospheres
generated from the ipsilateral SVZ compared with the
contralateral SVZ in EGF-supplemented media (1381¡105.2
compared with 511.5¡90.3, n56 brains), but no significant
difference in the number of spheres obtained from the
ipsilateral SVZ compared with the contralateral SVZ when
cultured in FGF-2-supplemented media (261.5¡32.4 com-
pared with 223.10¡24, n56 brains). There was no difference
in the number of neurospheres obtained from sham-operated
control SVZs in medium supplemented with EGF as compared
with FGF-2 (114.8¡42.2 compared with 82.9¡33.3, n56
brains). The addition of FGF-2 to the EGF-containing medium
had no effect on the outcome of this assay (Figure 1A).
Measuring the volume of the neurosphere can provide
insights into the proliferative capacity of the NSPs; therefore
we measured the diameter of at least ten neurospheres from
each culture condition (n56 SVZs per condition). The size of
the neurospheres obtained from the ipsilateral hemisphere of
the injured brain cultured in 2 ng/ml EGF was 17-fold larger
(P,0.05) compared with neurospheres from the ipsilateral
SVZs cultured in 1 ng/ml FGF-2 (470143.9¡79422.2 mm
3
compared with 26676.2¡7397.6 mm
3, n56b r a i n s ) .
Contralateral SVZ cells cultured in EGF-supplemented med-
ium were 2.5-fold larger (P,0.05) in size compared with their
counterparts cultured in FGF-2-supplemented medium
(27065.2¡9611.3 mm
3 compared with 11055.8¡1583.7
mm
3, n56 brains). There was no significant difference in
sham-operated control SVZ neurosphere sizes between EGF-
and FGF-2-supplemented media (7579.2¡2275.7 mm
3 com-
pared with 7833.4¡3273.4 mm
3). Lastly, there was a 62-fold
change in neurosphere size difference between ipsilateral
SVZ- and control SVZ-generated spheres in EGF-supplemen-
ted media (ipsilateral neurosphere, 470143.7¡79422 mm
3;
control neurosphere, 7579.2¡2275.7 mm
3) as compared with
a 3.4-fold change in FGF-2-supplemented media (ipsilateral
neurosphere, 26676.2¡7397.6 mm
3; control neurosphere,
7833.4¡3273.4 mm
3) (Figures 1A and 1C).
Pharmacologically inhibiting EGFR abrogates the
increase in precursors following neonatal H/I
To test the hypothesis that an increase in EGFR signalling was
responsible for the expansion of the neural progenitors during
recovery from neonatal H/I, we administered a commercially
available selective inhibitor of the EGFR, PD153035 (alterna-
tively named AG1517 or Compound 32) (Bos et al., 1997;
Lichtner et al., 2001). PD153035 is a competitive inhibitor of ATP
binding and, hence, prevents functional activation of the
receptor. This inhibitor also locks the receptors into inactive
dimers and thus reduces EGFR signalling. At 72 h post-H/I, SVZs
from ipsilateral and contralateral hemispheres, along with
sham-operated control SVZs, were dissected out and cultured in
ProN media supplementedwithEGF and FGF-2 alone or with the
addition of 300 nM or 1 mM PD153035. The neurosphere
numbers obtained were quantified at 7 DIV. PD153035 at both
300 nM and 1 mM abrogated the increase in neurosphere
number and size measured using the neurosphere assay. The
number of neurospheres obtained 7 DIV from the ipsilateral SVZ
at 3 day recovery from H/I cultured in growth-factor-
supplemented media containing 300 nM and 1 mM PD153035
were 5.5-fold and 16-fold lower (P,0.05) respectively,
compared with their counterparts cultured in the absence of
the inhibitor (ipsilateral SVZ cells: growth media, 916.8¡53.8;
+300 nM PD153035, 169.6¡43.2; +1 mM PD153035,
55.9¡12.3; n53 with six animals per experiment) (Figure 2).
Analogously, at 7 DIV, the number of neurospheres obtained
from the sham-operated control SVZs at 3 days of recovery
cultured in growth-factor-supplemented media containing 300
nM and 1 mM PD153035 were 3.6-fold and 6-fold lower
respectively (P,0.05) compared with their counterparts cul-
tured in growth-factor-supplemented media in the absence of
the inhibitor (control SVZ cells: growth media, 324.4¡104.06;
+300 nM PD153035, 88.5¡52.6; +1 mM PD153035, 54.1¡32.4;
n53 with six animals per experiment). The number of neuro-
spheres obtained from ipsilateral SVZs in 300 nM PD153035 was
not different from that of uninjured control SVZs cultured in
growth media containing EGF and FGF-2 (ipsilateral SVZ cells in
300 nM inhibitor, 169.6¡43.2; control SVZ cells in growth
media, 324.4¡104.1; n53 with six animals per experiment).
Finally, the numbers of neurospheres obtained in the presence
of either doses of the inhibitor (300 nM and 1 mM PD153035)
were not significantly different between injured ipsilateral SVZ
and sham-operated control SVZ at 3 day recovery from H/I (at
300 nM inhibitor: ipsilateral, 169.6¡43.1 and control,
88.5¡52.6; at 1 mM inhibitor: ipsilateral, 55.9¡12.3 and
control, 54.1¡32.4). Notably, FGF-2 at 1 ng/ml [the Kd of FGF-
2/FGFR (FGF receptor) 1 is 50 pM] was unable to recapitulate the
EGF effect upon inhibition of the EGFR activity (Figure 2).
H/I recruits more SVZ cells into the cell cycle and
they divide more rapidly in response to EGF
To determine whether the increase in neurosphere size
obtained from the ipsilateral SVZ in EGF-supplemented
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99medium was the result of altered cell-cycle kinetics, we
performed a cumulative [
3H]thymidine incorporation assay.
Cells isolated from ipsilateral, contralateral and sham-
operated control SVZs at 3 days of recovery from H/I were
cultured overnight in EGF-supplemented medium spiked with
8 mCi of [
3H]thymidine. The DNA was acid precipitated and
the radioactivity was quantified at 4 h intervals. This assay
revealed that a significantly greater number of cells in the
ipsilateral hemisphere achieved a higher level of
[
3H]thymidine incorporation compared with cells from the
contralateral and control hemispheres. By 16 h, the slope of
the rate of [
3H]thymidine from the ipsilateral SVZ began to
plateau with maximum incorporation of radioactivity reach-
ing approx. 2.5-fold and 10-fold higher levels compared with
contralateral and control respectively (at 16 h: ipsilateral,
2935.2 d.p.m.; contralateral, 1233 d.p.m.; control, 307.7
d.p.m.] (Figure 3). Analysing the slopes of the curves,
ipsilateral cells showed a 2.5-fold and 18-fold greater slope
between 4 and 16 h compared with contralateral and sham-
operated control SVZ cells respectively, indicating that the
cells in the ipsilateral SVZ cells have reduced cell-cycle time
following injury compared with sham-operated controls
(slope of ipsilateral, 182.58; slope of contralateral, 77.41;
slope of control, 10.09; between 4–16 h) (Figure 3).
Neonatal H/I increases the expression of EGFR
mRNA and protein levels, but not EGFR ligands
To determine whether the observed increase in neural stem/
progenitor numbers and alteration in cell-cycle kinetics
subsequent to injury could be attributed to increased EGF
responsiveness, we stained brain sections for EGFR at 48 h
after H/I and found that cells in the most medial aspect of the
Figure 1 Neurospheres grow larger in the presence of EGF, but not FGF-2
(A) SVZ cells were dissociated from ipsilateral (a and d), contralateral (b and e) and control (c and f) hemispheres at 3 days recovery
from H/I and cultured for 7 DIV in ProN medium supplemented with either 2 ng/ml EGF (a–c) or 1 ng/ml FGF-2 (d–f). Phase-contrast
images of representative neurospheres were captured for quantification. (B) Quantification of the average number of neurospheres
obtained per 50 000 SVZ cells. (C) Quantification of the average neurosphere size from at least 30 spheres. *P,0.05 using ANOVA
and Tukey’s post-hoc tests. Values are the mean number/size of neurospheres¡S.E.M. of three experiments with six animals per
experiment. IL, ipsilateral; CL, contralateral; CTL, control.
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pronounced increase in EGFR expression. Increased EGFR
expression, however, was also seen within most of the cells of
the dorsolateral SVZ. We also analysed EGFR mRNA expression
between 12 and 72 h of recovery. At 12 h post-H/I there was
a 1.5-fold increase (P,0.05) in EGFR mRNA in both the
ipsilateral and contralateral SVZs compared with sham-
operated controls (Figure 4). At 3 days recovery from H/I
the ipsilateral EGFR mRNA was increased by 3-fold (P,0.05)
relative to sham-operated controls, whereas the level of EGFR
expression in the contralateral hemispheres was not statist-
ically different from sham-operated controls. By 7 days post-
H/I injury, the levels of EGFR mRNA in the ipsilateral
hemisphere returned to levels comparable with those of
sham-operated controls (Figure 4). Surprisingly, there was no
change in the levels of the EGF or HB-EGF mRNAs, and the
level of the major EGFR brain ligand, TGF-a (transforming
growth factor-a), decreased to 50% in the ipsilateral
hemisphere compared with controls (Supplementary Figure
S1 at http://www.asnneuro.org/an/001/an001e009add.htm).
Figure 2 Pharmacologically inhibiting EGFR abrogates the in vitro NSP response observed following neonatal H/I
(A) SVZ cells were dissociated from ipsilateral (a–c) and control (d–f) hemispheres at 3 days recovery from H/I and cultured for 7 DIV
in ProN medium supplemented with 2 ng/ml EGF or 1 ng/ml FGF-2 along with the EGFR inhibitor PD153035 at 300 nM (b and e) or 1
mM (c and f) or with no inhibitor (a and d). (B) Quantification of the average number of neurospheres generated from ipsilateral and
control SVZ after 72 h recovery from H/I upon culturing in growth-factor-supplemented medium with or without the EGFR-specific
inhibitor PD153035. Values are the means¡S.E.M. of three independent experiments with n56 animals per experiment. *P,0.05, as
measured using a Student’s t test.
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101To establish whether the observed increase in EGFR mRNA
translated into greater EGFR protein expression, we per-
formed Western blot analysis on subfractionated SVZ
homogenates isolated from ipsilateral hemispheres 3 days
post-H/I and sham-operated control rat pups. The SVZ tissue
was homogenized and fractionated into cytosolic, nuclear
and membrane fractions. An analysis of the membrane
fractions revealed a 2.8-fold increase (P,0.05) in phosphory-
lated EGFR in the ipsilateral hemisphere relative to sham-
operated control SVZs at 72 h post-injury (Figure 5).
Injury increases EGFR expression in SVZ stem/
progenitor cells.
To investigate EGFR expression levels on stem and progenitor
cells, we performed flow cytometry for EGFR expression on
progenitors (PSA-NCAM and NG2 for rats) and stem cells (LeX
for mice). We used anti-NG2 and anti-PSA-NCAM antibodies
as they label several types of progenitors within the SVZ. At 3
days recovery from H/I, there was a 20-fold increase (P,0.05)
in EGFR
+/NG2
+ cells and a 17-fold increase (P,0.05) in the
EGFR
+/PSA-NCAM
+ cells in the ipsilateral SVZ as compared
with controls (Figures 6A, 6B, 7A and 7B). There was also a 7-
fold increase (P,0.05) in EGFR
+/NG2
2 and a 1.5-fold increase
(P,0.05) in EGFR
+/PSA-NCAM
2 cells in the damaged SVZ as
compared with controls (Figures 6C and 7C). No significant
change was found in the double-positive EGFR/NG2 cells or
EGFR/PSA-NCAM cells between the 72 h post-H/I contra-
lateral hemisphere and sham-operated control SVZ cells
(Figures 6B and 7B). Previously we found that progenitors,
expressing PSA-NCAM, are deleted early after H/I injury
(Romanko et al., 2004). The increase in the number of PSA-
NCAM
+/EGFR
+ cells probably reflects the effort to replace
these progenitors by augmenting their sensitivity to EGFR
ligands.
Figure 3 NSPs proliferate more rapidly in the presence of EGF following neonatal H/I
Animals were killed 3 days after H/I and neurospheres were cultured from ipsilateral (&), contralateral (¤) and control (N) SVZs in
20 ng/ml EGF overnight. The following morning [
3H]thymidine was added to the culture medium (8 mCi/ml). At 4 h intervals, cells
were collected on Whatman filter discs by vacuum, the DNA was precipitated with TCA and [
3H]thymidine incorporation was
quantified. This Figure shows one representative experiment from three repetitions, normalized to the 4 h control. Values are
means¡S.E.M.
Figure 4 H/I increases EGFR mRNA levels
Ipsilateral H/I and control SVZs were dissected and total RNA was extracted
and amplified by (A) semi-quantitative PCR using primers specific for EGFR
and normalized to the expression of GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) after 72 h of recovery; (B) real-time PCR using primers
specific for EGFR and normalized to expression of 18S after 2 h, 72 h and 7
day recovery (n56). The solid line represents EGFR expansion in sham-
operated animals. *P,0.05 as measured using the Student’s t test (A) and
REST (B).
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we used a mouse model of neonatal H/I wherein we could
identify putative mouse stem cells using the LeX/SSEA-1
marker. LeX is a fucose-containing trisaccharide that has
been reported to mark SVZ cells in the mouse brain that
possess stem cell properties (Capela and Temple, 2002).
Studies from our laboratory have shown that the murine SVZ
is similarly affected by H/I (Brazel et al., 2004), and that there
is an increase in murine neural stem/progenitor cells
following injury as observed by an increase in the numbers
Figure 5 H/I increases the levels of activated EGFR protein
(A–C) Cryostat sections (12 mm) from animals killed 48 h after H/I by intracardiac perfusion were stained for EGFR and
counterstained with DAPI. Panels are representative of the ipsilateral hemisphere (A), contralateral hemisphere (B) and an
immunostaining control (C). The scale bar represents 40 mm. To evaluate EGFR activation, H/I and control SVZs were dissected after
72 h recovery and the membranes were subfractionated (see the Materials and methods section) and 30 mg of each membrane
fraction was analysed by Western blot for total EGFR and for phosphorylated EGFR (D). The Western blots were quantified and
normalized to total receptor levels (E). Results are averaged from three independent experiments (n56). *P,0.05 (as measured using
a Student’s t test).
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103of neurospheres generated from the damaged hemisphere
compared with controls (Alagappan, 2008). Therefore cells
acutely dissociated from P12 mouse SVZ were stained for
EGFR and LeX and analysed by flow cytometry. This analysis
revealed a 27-fold increase (P,0.05) in the number of EGFR
+/
LeX
+ cells in ipsilateral SVZs compared with contralateral and
sham-operated control SVZs (Figure 8) (5.59¡1.4 compared
with 0.2¡0.04; 5.59¡1.4 compared with 0.2¡0.1; n56
brains). There was no statistical difference in the EGFR
+/LeX
+
population between the contralateral and sham-operated
control SVZ cells (contralateral, 0.2¡0.04; control, 0.2¡0.1;
n56 brains).
Recovery from H/I increases EGFR intensity on
SVZ stem/progenitors.
To determine whether H/I also increases the amount of EGFR
expressed per cell, we measured the geometric mean
fluorescence intensity of EGFR labelling in the progenitor
marker-positive as well as the LeX-positive stem cell
population in the ipsilateral and contralateral hemisphere
SVZs at 72 h post-H/I as compared with sham-operated
control SVZs in rats and mice. In rats, EGFR
+/progenitor
+
ipsilateral SVZ cells expressed 3-fold greater (P,0.05) EGFR
intensity compared with contralateral and sham-operated
control SVZ [ipsilateral, 46.3¡6.6 a.u. (arbitrary units);
contralateral, 15.9¡2.2 a.u.; control, 9.9¡1.4 a.u.; n56
brains] (Figures 9A and 9B). In mice, EGFR
+/LeX
+ ipsilateral
SVZ cells expressed 11-fold greater (P,0.05) EGFR intensity
compared with contralateral and sham-operated control SVZ
(ipsilateral, 21.7¡3.4 a.u.; contralateral, 1.9¡0.5 a.u.;
control, 1.3¡0.2 a.u.; n56 brains) (Figures 9C and 9D). Not
surprisingly, in rats, EGFR
+/progenitor
2 cells in the ipsilateral
SVZ showed a 1.5-fold increase (P,0.05) in the EGFR
intensity compared with the contralateral hemisphere and
sham-operated controls (ipsilateral, 8.5¡0.9 a.u.; contra-
lateral, 5.3¡0.5 a.u.; control, 3.9¡0.3 a.u.; n56 brains)
(Figure 9C). In addition, LeX intensity was also affected by H/I.
EGFR
+/LeX
+ ipsilateral SVZ cells expressed 17-fold greater
(P,0.05) LeX intensity compared with their counterparts in
the contralateral and sham-operated control SVZs (ipsilateral,
6.8¡1.3 a.u.; contralateral, 0.4¡0.1 a.u.; control, 0.2¡0.02
Figure 6 H/I increases the number of EGFR-positive NG2-expressing neural precursors in the rat SVZ
(A) Dot plot of EGFR
+/NG2
+ cells from the ipsilateral, contralateral and control SVZs after 72 h recovery from H/I. (B) Quantification
of the EGFR
+/NG2
+ neural precursors in the SVZ. (C) Quantification of EGFR
+/NG2
2 population, encompassing neural stem cells, in
the SVZ after injury. Values are the mean number¡S.E.M. and are from one representative experiment (n56 animals per
experiment). *P,0.05, measured using one-way ANOVA and Tukey’s post-hoc tests. IL, ipsilateral; CL, contralateral; CTL, control.
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difference in LeX intensity or EGFR intensity between
contralateral hemisphere and sham-operated control hemi-
spheres at 3 day recovery from H/I (LeX intensity: contra-
lateral, 0.4¡0.1 a.u.; control, 0.2¡0.02 a.u.; EGFR intensity:
contralateral, 1.9¡0.5 a.u.; control, 1.3¡0.2 a.u.; n56
brains) (Figures 8D and 8F).
EGFR overexpression is sufficient to recruit cells
into the cell cycle and decrease their cell-cycle
time.
To establish whether overexpressing EGFR is sufficient to
recruitcells into the cell cycle and to increase therate at which
they traverse through the cell cycle, we compared BrdU
incorporationintoSVZstem/progenitorcellstransfectedwitha
plasmid containing a constitutively active EGFR or a control
vector. The constitutively active EGFR plasmid increased the
number of cells in S-phase by 1.65-fold compared with
controls (pEGFR-IRES_EGFP, 16.6¡1.6; pEGFP, 10.1¡0.4;
n53 independent experiments) following a 6 h pulse with
BrdU (Figure 10E). EGFR overexpression also increased the
number of cells in G2/M-phase by 1.3-fold compared with
control cells (pEGFR-IRES_EGFP, 64.3¡1.4; pEGFP, 49.3¡4.3;
n53 independent experiments) in a 12 h period (Figure 10F).
A volumetric analysis of neurosphere size was performed
by measuring the diameter of at least 30 neurospheres from
each transfection condition per experiment. The size of the
neurospheres obtained from the constitutively active EGFR-
transfected cells were 5-fold and 32-fold larger (P,0.05)
compared with EGFR-transfected cells after 3 days and 7 days
in culture post-transfection respectively (3 day:
31609.67¡2820.4138 compared with 5831.27¡492.87
mm
3; 7 day: 2154943¡256683.7 compared with
66929.55¡8118.92 mm
3; n56 brains) (Figures 10C and 10D).
DISCUSSION
Many factors including TGF-a, FGF-2, insulin-like growth
factor 1, platelet-derived growth factor, neurotrophins,
ephrins, LIFR–CNTFR–gp130 complex, Notch 1, Sonic
Hedgehog and Wnts regulate the formation of the SVZ from
the ventricular zone in the developing brain (Carson et al.,
Figure 7 H/I increases the number of EGFR
+ PSA-NCAM-expressing progenitor neuroblasts in the rat SVZ
(A) Dot plot of EGFR
+/PSA-NCAM
+ cells from the ipsilateral, contralateral and control SVZs after 72 h recovery from H/I. (B)
Quantification of the EGFR
+/ PSA-NCAM
+ neural precursor population in the SVZ. (C) Quantification of the EGFR
+/PSA-NCAM
2
population, encompassing neural stem cells, in the SVZ after injury. Values represent the mean number¡S.E.M. and are from one
representative experiment with n56 animals per experiment. *P,0.05, measured using one-way ANOVA and Tukey’s post-hoc tests.
IL, ipsilateral; CL, contralateral; CTL, control.
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1051993; Vescovi et al., 1993; Weickert and Blum, 1995; Craig et
al., 1996; Johe et al., 1996; Kuhn et al., 1997; Shimazaki et al.,
2001; Doetsch et al., 2002; Giuliani et al., 2004; Hsieh et al.,
2004; Israsena et al., 2004; Palma et al., 2005; Felling et al.,
2006). These factors also regulate the proliferation and self-
renewal ofSVZstem/progenitorsand control theproduction of
neurons and macroglia. Currently it has not been established
which factor(s) among this pool of molecules is/are critically
involved in the expansion and proliferation of the endogenous
SVZ stem/progenitors for brain repair following injury. In the
present study we show that following neonatal H/I: (i)
quiescent SVZ cells enter the cell cycle; (ii) the increased
proliferation of these precursors occurs in response to EGF, but
not FGF-2; (iii) EGFR mRNA and protein expression increases in
SVZ; (iv) EGFR expression increases on progenitors and stem
cells within the SVZ; (v) EGFR acquisition increases the rate
that SVZcells traverse thecell cycle; and (vi) pharmacologically
inhibiting EGFR, even in the presence of FGF-2, reduces the in
vitro stem/progenitor expansion observed following injury,
confirming that FGF-2 stimulation cannot compensate for the
EGF-mediated regenerative response.
Both EGF and FGF-2 are mitogenic for adult neural stem/
progenitors. SVZ cells express FGF-2, FGFRs, EGF and EGFRs,
and signal transduction through these receptors is important
for their proliferation and self-renewal during embryonic and
postnatal development (Richards et al., 1992; Gritti et al.,
1996; Johe et al., 1996; Kuhn et al., 1997; Doetsch et al.,
1999; Gritti et al., 1999; Doetsch et al., 2002; Anton et al.,
2004; Fox and Kornblum, 2005). Intraventricular injection of
EGF expands the numbers of nestin
+ precursors in the SVZ
(Craig et al., 1996) and forced EGFR acquisition confers
migratory capacity to non-migratory postnatal neural
progenitors (Aguirre et al., 2005). In parallel, studies on
FGF-2 signalling have shown that FGF-2 is mitogenic for
multipotential adult murine forebrain precursors, maintains
the number of slowly dividing stem cells within the anterior
SVZ and FGF-2 knockouts have reduced numbers of dividing
neural stem cells and fewer olfactory bulb neurons (Gritti et
Figure 8 H/I increases the EGFR sensitivity on neural precursors in the rat SVZ
(A) Histogram plot of EGFR intensity within the neural-precursor-positive cells from the ipsilateral, contralateral and control SVZs
after 72 h recovery from H/I. (B) Quantification of the EGFR intensity (in a.u.) within the neural precursor population in the SVZ after
injury. (C) Quantification of the EGFR intensity (in a.u.) within the neural-precursor-negative, putative stem-cell-encompassing
population in the SVZ after injury. Values are the mean number¡S.E.M. of three independent experiments with n56 animals per
experiment. *P,0.05, measured using one-way ANOVA and Tukey’s post-hoc tests. IL, ipsilateral; CL, contralateral; CTL, control.
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present study, the expression of the EGFR increases within
nestin
+ cells located adjacent to ependymal cells during
recovery from middle cerebral artery occlusion in adult rats,
with peak expression occurring at 3 days post-ischaemia.
Furthermore, infusing EGF for 7 days into the cerebral
ventricles beginning 2 days after inducing ischaemia
stimulated striatal neurogenesis 100-fold compared with
vehicle-infused animals (Teramoto et al., 2003). Robust
induction of FGF-2 and FGFRs has been documented
following chronic hypoxia and this has been correlated with
increased neurogenesis (Ganat et al., 2002; Fagel et al., 2006).
However, we did not observe any increased cellular responses
to FGF-2 using the neurosphere assay, nor did FGF-2 infusion
stimulate enhanced neurogenesis after ischaemia in adult rats
(Teramoto et al., 2003) Thus the precise role and requirement
for FGF signalling in SVZ cellular responses to injury remain
incomplete.
In the present study we evaluated whether functional
activation of the EGFR is necessary and sufficient for the
proliferative response initiated by stem/progenitor cells of the
SVZ subsequent to brain injury. Studies from our laboratory,
as well as others, have documented a regenerative response
from the SVZ following neonatal H/I (Plane et al., 2004;
Felling et al., 2006). During the first week of recovery from a
moderate H/I insult, there is increased proliferation of cells in
the most medial aspect of the SVZ, as revealed by increased
BrdU uptake, as well as by increased numbers of nestin
+/
PCNA
+ (proliferating-cell nuclear antigen) cells in the most
medial aspect of the dorsolateral SVZ. This increase in cells in
S-phase within the region of the SVZ that harbours the stem
cells correlates with a doubling of the number of tripotential,
Figure 9 H/I increases the expression of EGFR-positive LeX-expressing putative stem cells in murine SVZ
(A) Dot plot of EGFR
+/LeX
+ cells from the ipsilateral, contralateral and control SVZs after 72 h recovery from H/I. (B) Quantification of
the EGFR
+/LeX
+ neural stem population in the SVZ after 72 h recovery from H/I. (C) Histogram plot of EGFR intensity within the LeX-
positive cells from the ipsilateral, contralateral and control SVZs after 72 h recovery from H/I. (D) Quantification of the EGFR intensity
(in a.u.) within the LeX-positive stem cell population in the SVZ after injury. (E) Histogram plot of LeX intensity from the ipsilateral,
contralateral and control SVZs after 72 h recovery from H/I. (F) Quantification of the LeX intensity (in a.u.) of SVZ cells after injury.
Values represent the mean number¡S.E.M. of three independent experiments with n56 animals per experiment. *P,0.05, measured
using one-way ANOVA and Tukey’s post-hoc tests. IL, ipsilateral; CL, contralateral; CTL, control.
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107self-renewing NSPs as measured using the neurosphere assay.
Fate-mapping studies have shown that there is a subsequent
emigration of neuronal and glial progenitors from the SVZ to
repopulate subcortical and neocortical structures (Plane et al.,
2004; Ong et al., 2005; Felling et al., 2006; Yang and Levison,
2006; Yang et al., 2007; Yang and Levison, 2007). However, the
extent of stem cell expansion and the resulting regeneration
following injury is modest. Therefore our most recent studies
have focused on understanding the signals that regulate these
processestowardsachievinga morerobustamplificationofthe
stem/progenitor cell pool and more significant repair.
In a key experiment we abolished the in vitro expansion of
SVZ NSPs by pharmacologically inhibiting functional EGFR
activation in the presence of FGF-2. We used the quinazoline
PD153035, a reversible tyrosine kinase inhibitor specific to
EGFR. In vitro, PD153035 inhibits EGF-dependent cellular
processes completely at doses ranging up to 1 mM whereas
PDGF-, FGF-2-, and serum-dependent mitogenesis is inhibited
only at concentrations higher than 5 mM (Fry et al., 1994).
PD153035 is the parent compound of several 4-aniloquina-
zolines in the clinic such as Iressa (Astra-Zeneca), Tarceva
(Roche/Genentech), GW 2016 (GlaxoSmithKline) and CI-1033
Figure 10 EGFR overexpression is sufficient to increase cell-cycle kinetics of SVZ NSPs
(A and B) pEF2-ATG-FL-EGFP and pEF2-fl-Fc-EGFR-IRES-EGFP plasmids. (C) Neurospheres generated at 3 days and 7 days following
transfection with pEGFP and pEGFR-IRES-EGFP into SVZ NSPs. (D) Quantification of neurosphere size obtained from (C). (E)
Percentage of cells in S-phase after a 6 h BrdU pulse and in G2/M-phase (F). Values represent the mean number¡S.E.M. of three
independent experiments with n56 animals per experiment. *P,0.05, measured using a Student’s t test.
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nM PD153035 to block EGFR activation during stimulation
with FGF-2. At this dose, we found that the number of
neurospheres obtained in the presence of the inhibitor at 72
h post-H/I from the damaged ipsilateral hemisphere was
comparable with sham-operated control SVZs indicating that
FGF-2 signalling cannot compensate for the loss of EGFR
signalling, and EGFR activation is necessary for the observed
reactive expansion of the NSPs subsequent to an ischaemic
insult. The above compounds gain access to the CNS, whereas
PD153035 is excluded. It would have been informative to use
these inhibitors for in vivo experiments; however, the
manufacturers of these drugs denied our requests for these
reagents.
Complementary studies to the loss-of-function experiment
were performed using a novel technology to introduce a
constitutively active EGFR into the NSPs. Acquisition of this
functionally active EGFR enhanced the number of cells
traversing the cell cycle. This was manifested as an increase in
neurosphere size obtained from EGFR-overexpressing SVZ
NSPs compared with GFP-transfected cells. Thus augmenting
EGFR signalling is sufficient to recapitulate in vitro the
increased regenerative NSP response observed ex vivo after
injury.
A subset of tripotential neural progenitors in the postnatal
brain expressing the NG2 proteoglycan can migrate to the
subcortical white matter and to the olfactory bulb via the
rostral migratory stream. Several studies have shown that
acquisition of EGFR by neural progenitors correlates with
their ability to proliferate and migrate (Aguirre and Gallo,
2004; Aguirre et al., 2005; Ivkovic et al., 2008). SVZ cells
migrate into damaged white and grey matter after H/I as we,
and others, have shown. These studies have implicated
chemokines such as MCP-1 (monocyte chemoattractant
protein-1) and SDF-1a (stromal-cell-derived factor-1a)a s
stimulators of progenitor cell emigration post-stroke (Miller
et al., 2005; Yang et al., 2007). In light of the above studies
substantiating a role for the EGFR in the migration of glial
progenitors in remyelination, our results suggest a previously
unanticipated role for the EGFR in progenitor cell migration
post-ischaemic injury.
To establish whether EGFR acquisition following injury is
conserved across species, and to determine whether it is
induced on neural stem cells, we evaluated the expression of
EGFR on LeX
+ SVZ cells. LeX/SSEA-1 is a surface carbohydrate
moiety expressed by a small population of mouse SVZ cells
that retain sustained proliferation and self-renewal capabil-
ities characteristic of SVZ stem cells (Capela and Temple,
2002; Maric et al., 2003; Imura et al., 2006). Upon injury, the
numbers of EGFR
+/LeX
+ cells increased significantly in the
regenerating SVZ. We have also confirmed in the rat that the
EGFR increases in the progenitor marker-negative population
using the strategy developed by Maric et al. (2003) and have
observed a similar increase of EGFR
+ cells that are
Aldefluor
TM+ in the neonatal SVZ after H/I (Alagappan,
2008). These results are consistent with our previous in situ
and neurosphere analyses that indicate that the brain
initiates an active expansion of SVZ stem cells, which is not
simply an activation of pre-existing quiescent stem cells for
repair.
We employed a cumulative thymidine incorporation assay
to evaluate cell-cycle kinetics acutely following injury. This
analysis affirmed an alteration in stem/progenitor behaviour
upon EGF treatment. In this assay, the height at which the
curve plateaus is a measure of the number of cells recruited
into cell cycle and the slope of the curve provides an index of
the cell-cycle time, with a steeper slope indicating a shorter
cell-cycle time (Yu et al., 1996; Khanna, 2005; Khanna and
Mehra, 2006). We specifically adopted cumulative thymidine
labelling compared with pulse labelling because serum
starvation, typically used to synchronize cells prior to cell-
cycle analysis, is not technically feasible with NSPs. Averaging
across experiments, approx. ten times as many cells from the
injured brain entered the cell cycle and they divided
significantly faster compared with uninjured controls in the
presence of EGF. SVZ cells from the contralateral SVZ also
divided more rapidly, analogous to previously reported
neurosphere assay data (Felling et al., 2006). Taken together,
these results suggest that acquisition of EGFR by the SVZ cells
following injury not only expands the numbers of stem cells,
but that it recruits quiescent cells to enter the cell cycle and
stimulates these precursors to transit through the cell cycle
faster compared with uninjured controls. These results are
reminiscent of published studies in cancer biology that show
that activation of EGFR destabilizes cell-cycle inhibitor
proteins to enable quiescent cells to enter the cell cycle
(Lenferink et al., 2000; Boerner et al., 2005).
In conclusion, the present study demonstrates that the
EGFR is a key mediator of the regenerative response elicited
from the stem cell and progenitor cell pools within the SVZ
subsequent to brain injury. EGFR expression is elevated in SVZ
cells, which recruits relatively quiescent cells to cycle more
rapidly. The in vitro response of the SVZ stem/progenitors is
manifested by an increase in neurosphere size and number,
which can be abolished by a pharmacological inhibitor
specific to EGFR in the presence of FGF-2 and is mimicked by
overexpressing the EGFR. The increase in EGFR sensitivity
acquired will promote their expansion and hence can
participate in their migration into pallial and subpallial
structures to aid repair. We also show that EGFR levels return
to control levels within a few days, therefore strategies to
augment EGFR signalling may represent important avenues to
pursue to initiate a robust response from the resident SVZ
NSPs following injury for functional brain recovery.
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